These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 3021849)

  • 1. Isolation of soluble yeast beta-glucans that inhibit human monocyte phagocytosis mediated by beta-glucan receptors.
    Janusz MJ; Austen KF; Czop JK
    J Immunol; 1986 Nov; 137(10):3270-6. PubMed ID: 3021849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
    Czop JK; Austen KF
    J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a yeast heptaglucoside that inhibits monocyte phagocytosis of zymosan particles.
    Janusz MJ; Austen KF; Czop JK
    J Immunol; 1989 Feb; 142(3):959-65. PubMed ID: 2643666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbation of beta-glucan receptors on human neutrophils initiates phagocytosis and leukotriene B4 production.
    Czop JK; Puglisi AV; Miorandi DZ; Austen KF
    J Immunol; 1988 Nov; 141(9):3170-6. PubMed ID: 2844908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal enzyme release from human monocytes by particulate activators is mediated by beta-glucan inhibitable receptors.
    Janusz MJ; Austen KF; Czop JK
    J Immunol; 1987 Jun; 138(11):3897-901. PubMed ID: 3035014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway.
    Czop JK; Austen KF
    J Immunol; 1985 Apr; 134(4):2588-93. PubMed ID: 2579146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phagocytosis of particulate activators of the human alternative complement pathway through monocyte beta-glucan receptors.
    Czop JK; Valiante NM; Janusz MJ
    Prog Clin Biol Res; 1989; 297():287-96. PubMed ID: 2555820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and isolation of rabbit anti-idiotypic antibodies directed against the human monocyte receptor for yeast beta-glucans.
    Czop JK; Gurish MF; Kadish JL
    J Immunol; 1990 Aug; 145(3):995-1001. PubMed ID: 1695652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis of heat-killed blastospores of Candida albicans by human monocyte beta-glucan receptors.
    Janusz MJ; Austen KF; Czop JK
    Immunology; 1988 Oct; 65(2):181-5. PubMed ID: 2847978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phagocytosis of unopsonized zymosan particles by trypsin-sensitive and beta-glucan-inhibitable receptors on bone marrow-derived murine macrophages.
    Kadish JL; Choi CC; Czop JK
    Immunol Res; 1986; 5(2):129-38. PubMed ID: 3020136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of leukotrienes by human monocytes upon stimulation of their beta-glucan receptor during phagocytosis.
    Czop JK; Austen KF
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2751-5. PubMed ID: 2986134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human polymorphonuclear leucocytes by particulate zymosan is related to both its major carbohydrate components: glucan and mannan.
    Williams JD; Topley N; Alobaidi HM; Harber MJ
    Immunology; 1986 May; 58(1):117-24. PubMed ID: 3710519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of a beta-1,3-D-glucan receptor in P388D1 cells treated with retinoic acid or 1,25-dihydroxyvitamin D3.
    Goldman R
    Immunology; 1988 Feb; 63(2):319-24. PubMed ID: 2832311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators.
    Williams JD; Czop JK; Austen KF
    J Immunol; 1984 Jun; 132(6):3034-40. PubMed ID: 6327815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of membrane complement receptor type three (CR3) for beta-glucans.
    Ross GD; Cain JA; Myones BL; Newman SL; Lachmann PJ
    Complement; 1987; 4(2):61-74. PubMed ID: 3040332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of the beta-glucan receptor of murine macrophages.
    Goldman R
    Exp Cell Res; 1988 Feb; 174(2):481-90. PubMed ID: 2828085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.
    Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD
    J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminarin, a soluble beta-glucan, inhibits macrophage phagocytosis of zymosan but has no effect on lipopolysaccharide mediated augmentation of phagocytosis.
    Fuentes AL; Millis L; Sigola LB
    Int Immunopharmacol; 2011 Nov; 11(11):1939-45. PubMed ID: 21856445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.
    Schlesinger LS; Bellinger-Kawahara CG; Payne NR; Horwitz MA
    J Immunol; 1990 Apr; 144(7):2771-80. PubMed ID: 2108212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism.
    Wilson ME; Pearson RD
    J Immunol; 1986 Jun; 136(12):4681-8. PubMed ID: 3711662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.